Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study Academic Article uri icon

Overview

MeSH Major

  • Hepatitis C
  • Liver Transplantation
  • Living Donors
  • Severity of Illness Index
  • Tissue Donors
  • Transplantation

abstract

  • Donor type does not affect the probability of advanced fibrosis or patient and graft survival in HCV-infected recipients. Thus, while LDLT offers the advantage of shorter wait times, there is no apparent benefit for HCV disease progression. Biliary strictures have a negative effect on HCV fibrosis severity and graft survival, and a high AST at LT may be an important predictor of fibrosis risk post-LT.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4118586

Digital Object Identifier (DOI)

  • 10.1002/hep.26920

PubMed ID

  • 24677192

Additional Document Info

start page

  • 1311

end page

  • 9

volume

  • 59

number

  • 4